Loading company…
Matchpoint Therapeutics develops covalent medicines and a platform for exploring covalent compounds.
Matchpoint Therapeutics, Inc. is a biotechnology company based in Massachusetts, US, developing covalent medicines. Its products include covalent drugs and the Advanced Covalent Exploration (ACE) platform, which supports pathogenic protein identification and provides proprietary libraries of covalent compounds. In 2022, the company raised USD 30 million in seed funding co-led by Atlas Venture and Access Industries.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in